Published January 2004
| Version v1
Miscellaneous
Well differentiated thyroid carcinoma treatment with 131i and its follow up in Paraguay
Creators
- 1. Department of Nuclear Medicine at the Health Sciences Research Institute, National University of Asuncion (Paraguay)
- 2. Department of Surgery, Nazarene Hospital (Paraguay)
Description
Paraguay is a South American country with the highest prevalence in goiter (48.6%). During a 15-year period, from 1987 to 2002, 200 patients with well differentiated thyroid carcinoma were treated with 131I, post-surgery at ages between 18 and 60 years old
Availability note (English)
Available from Centro de Informacion Nuclear, Comision Nacional de Energia Atomica, Universidad Nacional de Asuncion, San Lorenzo CP 2169, PO Box 3029 Asuncion (PY)
Additional details
Identifiers
- URL
- https://www.una.py/;
Publishing Information
- Imprint Pagination
- 7 p.
INIS
- Country of Publication
- Paraguay
- Country of Input or Organization
- Paraguay
- INIS RN
- 35105805
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- CARCINOMAS; IODINE 131; NUCLEAR MEDICINE; RADIOTHERAPY; THYROID
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; THERAPY